Abivax appoints head of investor relations
Based in Abivax's East Coast subsidiary, Patrick Malloy brings 20 years of experience in investor relations and commercial leadership in the biopharmaceutical sector.
He joins Abivax from VectivBio AG (acquired by Ironwood Pharmaceuticals in June), where he was Senior Vice President of Investor Relations and Strategic Communications.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction